Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study.

被引：0

作者：

Mohty, Mohamad

Tomasson, Michael H.

Arnulf, Bertrand

Bahlis, Nizar J.

Prince, H. Miles

Niesvizky, Ruben

Rodriguez-Otero, Paula

Martinez-Lopez, Joaquin

Koehne, Guenther

Jethava, Yogesh

Gabayan, A. Eli

Stevens, Don A.

Nooka, Ajay K.

Raje, Noopur S.

Iida, Shinsuke

Leip, Eric

Conte, Umberto

Czibere, Akos Gabor

Viqueira, Andrea

Lesokhin, Alexander M.

机构：

[1] Sorbonne Univ, Hop St Antoine, Paris, France

[2] INSERM UMRs938, Paris, France

[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA

[4] Hop St Louis, Paris, France

[5] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[6] Epworth Healthcare, Melbourne, Vic, Australia

[7] Weill Cornell Med Coll, New York Presbyterian Hosp, New York, NY USA

[8] Univ Navarra Clin, Madrid, Spain

[9] Hosp Univ 12 OCTUBRE, Madrid, Spain

[10] Miami Canc Inst, Miami, FL USA

[11] Indiana Blood & Marrow Transplant, Indianapolis, IN USA

[12] Beverly Hills Canc Ctr, Beverly Hills, CA USA

[13] Norton Canc Inst, Louisville, KY USA

[14] Emory Univ Hosp, Winship Canc Inst, Atlanta, GA USA

[15] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[16] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[17] Pfizer Inc, Cambridge, MA USA

[18] Pfizer Inc, New York, NY USA

[19] Pfizer SLU, Madrid, Spain

[20] Mem Sloan Kettering Canc Ctr, Div Hematol & Oncol, Weill Cornell Med Coll, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8039

引用

页数：1

共 50 条

[41] Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma
Moreau, Philippe
Usmani, Saad Z.
Garfall, Alfred L.
van de Donk, Niels W. C. J.
Nahi, Hareth
San-Miguel, Jesus
Oriol, Albert
Nooka, Ajay K.
Martin, Thomas
Rosino, Laura
Chari, Ajai
Karlin, Lionel
Benboubker, Lotfi
Mateos, Maria-Victoria
Bahlis, Nizar J.
Popat, Rakesh
Besemer, Britta
Martínez-López, Joaquín
Sidana, Surbhi
Pei, Lixia
Trancucci, Danielle
Verona, Raluca I.
Girgis, Suzette
Olyslager, Yunsi
Jaffe, Mindy
Uhlar, Clarissa M.
Stephenson, Tara
Van Rampelbergh, Rian
Banerjee, Arnob
Goldberg, Jenna D.
Kobos, Rachel
Krishnan, Amrita Y.
BLOOD, 2021, 138
[42] Elranatamab in Combination with Daratumumab for Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 3 Magnetismm-5 Study Safety Lead-in Cohort
Grosicki, Sebastian
Mellqvist, Ulf-Henrik
Pruchniewski, Lukasz
Crafoord, Jacob
Trudel, Suzanne
Min, Chang-Ki
White, Darrell
Alegre, Adrian
Hansson, Markus
Ikeda, Takashi
Sunami, Kazutaka
Leip, Eric
Kudla, Arthur
Finn, Gregory
Koh, Youngil
BLOOD, 2022, 140 : 4407 - 4408
[43] Gene therapy with B-cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma
Peng, Fengping
Wang, Yuan
Zhao, Jiliang
Liu, Hui
Liu, Zhaoyun
Ding, Kai
Zhang, Hongkai
Fu, Rong
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (03) : 417 - 421
[44] A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen x CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
D'Souza, Anita
Shah, Nina
Rodriguez, Cesar
Voorhees, Peter M.
Weisel, Katja
Bueno, Orlando F.
Pothacamury, Rajvineeth K.
Freise, Kevin J.
Yue, Susan
Ross, Jeremy A.
Polepally, Akshanth R.
Talati, Chetasi
Lee, Shane
Jin, Ziyi
Buelow, Ben
Vij, Ravi
Kumar, Shaji
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3576 - +
[45] Outcomes of Patients Who Are BCMA (B-cell maturation Antigen) Directed Therapy (BDT) Exposed Vs BCMA Naive in Penta-Relapsed Refractory Multiple Myeloma (RRMM)
Mammadzadeh, Aytaj
Peng, Fulei
Atrash, Shebli
Hashmi, Hamza
Mohan, Meera
Alkharabsheh, Omar
Afrough, Aimaz
Cui, Wei
Mahmoudjafari, Zahra
Abdallah, Al-Ola
BLOOD, 2022, 140 : 4277 - 4278
[46] OPTec: A phase 2 study to evaluate outpatient (OP) step-up administration of teclistamab (Tec), a BCMA-targeting bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
Rifkin, Robert M.
Schade, Henning Helmut
Simmons, Gary
Yasenchak, Christopher A.
Fowler, Jessica
Lin, Thomas S.
Thomson, Brian
Xu, Weiming
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[47] Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study
Wong, Sandy W.
Bar, Noffar
Paris, Laura
Hofmeister, Craig C.
Hansson, Markus
Santoro, Armando
Mateos, Maria-Victoria
Rodriguez-Otero, Paula
Lund, Johan
Encinas, Cristina
Yee, Andrew J.
Oriol, Albert
Cerchione, Claudio
de la Rubia, Javier
Ferstl, Barbara
Carlson, Kristina
Ribas, Paz
Bermudez, Arancha
Boss, Isaac W.
Gaudy, Allison
Li, Shaoyi
Hsu, Kevin
Godwin, Colin D.
Burgess, Michael R.
San-Miguel, Jesus
Costa, Luciano J.
BLOOD, 2022, 140
[48] Initial Results of a Phase I Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Relapsed/Refractory Multiple Myeloma
Rodriguez, Cesar
D'Souza, Anita
Shah, Nina
Voorhees, Peter M.
Ben Buelow
Vij, Ravi
Kumar, Shaji K.
BLOOD, 2020, 136
[49] A Phase 1 First-in-Human Study of Tnb-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
Kumar, Shaji
D'Souza, Anita
Shah, Nina
Rodriguez, Cesar
Voorhees, Peter M.
Bueno, Orlando F.
Ben Buelow
Freise, Kevin J.
Yue, Susan
Pothacamury, Rajvineeth Kumar
Polepally, Akshanth R.
Vij, Ravi
BLOOD, 2021, 138
[50] A Phase I, Open-Label Study to Evaluate the Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity of PF-06863135, a B-Cell Maturation Antigen/CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Advanced Multiple Myeloma
Lesokhin, Alexander M.
Raje, Noopur
Gasparetto, Cristina J.
Walker, Justine
Krupka, Heike I.
Joh, Tenshang
Taylor, Carrie T.
Jakubowiak, Andrzej
BLOOD, 2018, 132

← 1 2 3 4 5 →